Compare CLNN & SUNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CLNN | SUNS |
|---|---|---|
| Founded | 2012 | 2023 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 120.6M | 124.1M |
| IPO Year | N/A | N/A |
| Metric | CLNN | SUNS |
|---|---|---|
| Price | $5.18 | $9.10 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 6 | 3 |
| Target Price | ★ $32.67 | $13.00 |
| AVG Volume (30 Days) | 96.2K | ★ 125.2K |
| Earning Date | 11-13-2025 | 03-05-2026 |
| Dividend Yield | N/A | ★ 13.13% |
| EPS Growth | N/A | ★ 1112.46 |
| EPS | N/A | ★ 1.09 |
| Revenue | $214,000.00 | ★ $19,384,703.00 |
| Revenue This Year | N/A | $174.58 |
| Revenue Next Year | $92.84 | $60.45 |
| P/E Ratio | ★ N/A | $8.38 |
| Revenue Growth | N/A | ★ 2540.16 |
| 52 Week Low | $2.28 | $7.80 |
| 52 Week High | $13.50 | $14.32 |
| Indicator | CLNN | SUNS |
|---|---|---|
| Relative Strength Index (RSI) | 36.44 | 36.05 |
| Support Level | $4.50 | $9.05 |
| Resistance Level | $6.68 | $9.49 |
| Average True Range (ATR) | 0.61 | 0.29 |
| MACD | -0.01 | -0.07 |
| Stochastic Oscillator | 31.06 | 2.77 |
Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. It developed an electro-crystal-chemistry drug development platform that enables the production of concentrated, stable, clean-surfaced nanocrystal suspensions. It operates in one segment the development and commercialization of dietary supplements (Supplements). Products includes CNM-Au8, CNM-ZnA, CNM-AgZn17, rMetx, KHC46.
Sunrise Realty Trust Inc is a real estate investment trust company. It is focus on originating CRE debt investments and providing capital to high-quality borrowers and sponsors with transitional business plans collateralized by CRE assets with opportunities for near-term value creation, as well as recapitalization opportunities. It intends to create a diversified investment portfolio, targeting investments in senior mortgage loans, mezzanine loans, whole loans, B-notes, CMBS and debt-like preferred equity securities across CRE asset classes and investment mix to include high quality multi-family, condominiums, retail, office, hospitality, industrial, mixed use and specialty-use real estate.